These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


340 related items for PubMed ID: 32421442

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
    Katzenstein HM, London WB, Douglass EC, Reynolds M, Plaschkes J, Finegold MJ, Bowman LC.
    J Clin Oncol; 2002 Aug 15; 20(16):3438-44. PubMed ID: 12177104
    [Abstract] [Full Text] [Related]

  • 25. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89.
    von Schweinitz D, Hecker H, Harms D, Bode U, Weinel P, Bürger D, Erttmann R, Mildenberger H.
    J Pediatr Surg; 1995 Jun 15; 30(6):845-52. PubMed ID: 7545228
    [Abstract] [Full Text] [Related]

  • 26. Successful treatment of young childhood standard-risk hepatoblastoma with cisplatin monotherapy using a central review system.
    Saeki I, Ida K, Kurihara S, Watanabe K, Mori M, Hishiki T, Yokoi A, Fujimura J, Honda S, Nogami Y, Iehara T, Kazama T, Sekiguchi M, Kitagawa N, Matsumura R, Nomura M, Yamada Y, Hanaki R, Kaneda H, Takama Y, Inoue T, Tanaka Y, Miyazaki O, Nagase H, Takimoto T, Yoshimura K, Hiyama E.
    Pediatr Blood Cancer; 2024 Nov 15; 71(11):e31255. PubMed ID: 39126361
    [Abstract] [Full Text] [Related]

  • 27. High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99.
    Häberle B, Maxwell R, Schweinitz DV, Schmid I.
    Klin Padiatr; 2019 Nov 15; 231(6):283-290. PubMed ID: 31645068
    [Abstract] [Full Text] [Related]

  • 28. [Surgical therapy of hepatoblastoma in childhood].
    von Schweinitz D, Hecker H, Bürger D, Mildenberger H.
    Langenbecks Arch Chir; 1995 Nov 15; 380(6):315-20. PubMed ID: 8558999
    [Abstract] [Full Text] [Related]

  • 29. Outcomes for high-risk hepatoblastoma in a resource-challenged setting.
    Rammohan A, Rela M, Kumar GV, Scott JX, Shanmugam N, Reddy MS, Ramachandran P.
    BJS Open; 2020 Aug 15; 4(4):630-636. PubMed ID: 32379933
    [Abstract] [Full Text] [Related]

  • 30. Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma.
    Matsunaga T, Sasaki F, Ohira M, Hashizume K, Hayashi A, Hayashi Y, Mugishima H, Ohnuma N, Japanese Study Group for Pediatric Liver Tumor.
    Pediatr Surg Int; 2003 May 15; 19(3):142-6. PubMed ID: 12768314
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Treatment of hepatoblastoma: less extensive hepatectomy after effective preoperative chemotherapy with cisplatin and adriamycin.
    Seo T, Ando H, Watanabe Y, Harada T, Ito F, Kaneko K, Horibe K, Sugito T, Ito T.
    Surgery; 1998 Apr 15; 123(4):407-14. PubMed ID: 9551066
    [Abstract] [Full Text] [Related]

  • 33. Clinical Characteristics and Outcomes of Neonatal Hepatoblastoma: A Single Center Study.
    Zhou J, Yang L, Fu T, Gao H, Shan Y, Wang J, Zhang L, Xie C, Yin M, Ma J, Pan Q, Xu M, Gu S.
    J Pediatr Surg; 2024 Nov 15; 59(11):161640. PubMed ID: 39174446
    [Abstract] [Full Text] [Related]

  • 34. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
    Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P.
    Lancet Oncol; 2017 Jan 15; 18(1):122-131. PubMed ID: 27884679
    [Abstract] [Full Text] [Related]

  • 35. Extreme hepatic resections for the treatment of advanced hepatoblastoma: Are planned close margins an acceptable approach?
    Fonseca A, Gupta A, Shaikh F, Ramphal R, Ng V, McGilvray I, Gerstle JT.
    Pediatr Blood Cancer; 2018 Feb 15; 65(2):. PubMed ID: 28921939
    [Abstract] [Full Text] [Related]

  • 36. Is multifocality a prognostic factor in childhood hepatoblastoma?
    Saettini F, Conter V, Provenzi M, Rota M, Giraldi E, Foglia C, Cavalleri L, D'Antiga L.
    Pediatr Blood Cancer; 2014 Sep 15; 61(9):1593-7. PubMed ID: 24757164
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group.
    Dall'Igna P, Brugieres L, Christin AS, Maibach R, Casanova M, Alaggio R, de Goyet JV, Zsiros J, Morland B, Czauderna P, Childs M, Aronson DC, Branchereau S, Brock P, Perilongo G.
    Pediatr Blood Cancer; 2018 Jan 15; 65(1):. PubMed ID: 28921839
    [Abstract] [Full Text] [Related]

  • 39. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.
    O'Neill AF, Towbin AJ, Krailo MD, Xia C, Gao Y, McCarville MB, Meyers RL, McGahren ED, Tiao GM, Dunn SP, Langham MR, Weldon CB, Finegold MJ, Ranganathan S, Furman WL, Malogolowkin M, Rodriguez-Galindo C, Katzenstein HM.
    J Clin Oncol; 2017 Oct 20; 35(30):3465-3473. PubMed ID: 28892430
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.